Non-motor symptoms in amyotrophic lateral sclerosis: lessons from Parkinson’s disease

References

• Brown RH, Jr., Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377:1602.
   PubMed Web of Science ®Google Scholar
• Martin S, Al Khleifat A, Al-Chalabi A. What causes amyotrophic lateral sclerosis? F1000Res. 2017;6:371.
   PubMedGoogle Scholar
• Al-Chalabi A, Kwak S, Mehler M, Rouleau G, Siddique T, Strong M, et al. Genetic and epigenetic studies of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14 Suppl 1:44–52.
   PubMed Web of Science ®Google Scholar
• Tiryaki E, Horak HA. ALS and other motor neuron diseases. Continuum. 2014;20:1185–207.
   PubMedGoogle Scholar
• Rusina R, Vandenberghe R, Bruffaerts R. Cognitive and behavioral manifestations in ALS: beyond motor system involvement. Diagnostics. 2021;11:624.
   Web of Science ®Google Scholar
• Abrahams S, Newton J, Niven E, Foley J, Bak TH. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:9–14.
   PubMed Web of Science ®Google Scholar
• Fang T, Jozsa F, Al-Chalabi A. Nonmotor symptoms in amyotrophic lateral sclerosis: A systematic review. Int Rev Neurobiol 2017;134:1409–41.
   PubMed Web of Science ®Google Scholar
• Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015;30:1591–601.
   PubMed Web of Science ®Google Scholar
• Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol. 2006;5:235–45.
   PubMed Web of Science ®Google Scholar
• Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Chaudhuri KR, Group NV. The impact of non-motor symptoms on health-related quality of life of patients with Parkinson’s disease. Mov Disord. 2011;26:399–406.
   PubMed Web of Science ®Google Scholar
• Postuma RB, Berg D. Advances in markers of prodromal Parkinson disease. Nat Rev Neurol. 2016;12:622–34.
   PubMed Web of Science ®Google Scholar
• Schapira AHV, Chaudhuri KR, Jenner P. Non-motor features of Parkinson disease. Nat Rev Neurosci. 2017;18:509.
   PubMed Web of Science ®Google Scholar
• Urso D, Zoccolella S, Gnoni V, Logroscino G. Amyotrophic lateral sclerosis-the complex phenotype-from an epidemiological perspective: a focus on extrapyramidal and non-motor features. Biomedicines 2022;10:2537.
   PubMed Web of Science ®Google Scholar
• Crockford C, Newton J, Lonergan K, Chiwera T, Booth T, Chandran S, et al. ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS. Neurology 2018;91:e1370–e80.
   PubMed Web of Science ®Google Scholar
• Al Khleifat A, Iacoangeli A, van Vugt J, Bowles H, Moisse M, Zwamborn RAJ, et al. Structural variation analysis of 6,500 whole genome sequences in amyotrophic lateral sclerosis. NPJ Genom Med. 2022;7:8.
   PubMed Web of Science ®Google Scholar
• McLaughlin RL, Schijven D, van Rheenen W, van Eijk KR, O'Brien M, Kahn RS, et al. Genetic correlation between amyotrophic lateral sclerosis and schizophrenia. Nat Commun. 2017;8:14774.
   PubMed Web of Science ®Google Scholar
• Huynh W, Sharplin LE, Caga J, Highton-Williamson E, Kiernan MC. Respiratory function and cognitive profile in amyotrophic lateral sclerosis. Eur J Neurol. 2020;27:685–91.
   PubMed Web of Science ®Google Scholar
• Chio A, Mora G, Lauria G. Pain in amyotrophic lateral sclerosis. Lancet Neurol. 2017;16:144–57.
   PubMed Web of Science ®Google Scholar
• Handy CR, Krudy C, Boulis N, Federici T. Pain in amyotrophic lateral sclerosis: a neglected aspect of disease. Neurol Res Int. 2011;2011:403808.
   PubMedGoogle Scholar
• Nichols NL, Van Dyke J, Nashold L, Satriotomo I, Suzuki M, Mitchell GS. Ventilatory control in ALS. Respir Physiol Neurobiol. 2013;189:429–37.
   PubMed Web of Science ®Google Scholar
• Lopes de Carvalho ML, Motta R, Battaglia MA, Brichetto G. Urinary disorders in amyotrophic lateral sclerosis subjects. Amyotroph Lateral Scler. 2011;12:352–5.
   PubMed Web of Science ®Google Scholar
• Nubling GS, Mie E, Bauer RM, Hensler M, Lorenzl S, Hapfelmeier A, et al. Increased prevalence of bladder and intestinal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:174–9.
   PubMed Web of Science ®Google Scholar
• Kihira T, Yoshida S, Yoshimasu F, Wakayama I, Yase Y. Involvement of Onuf’s nucleus in amyotrophic lateral sclerosis. J Neurol Sci. 1997;147:81–8.
   PubMed Web of Science ®Google Scholar
• Papadopoulou M, Bakola E, Papapostolou A, Stefanou MI, Moschovos C, Salakou S, et al. Autonomic dysfunction in amyotrophic lateral sclerosis: a neurophysiological and neurosonology study. J Neuroimaging. 2022;32:710–9.
   PubMed Web of Science ®Google Scholar
• Brown AA, Ferguson BJ, Jones V, Green BE, Pearre JD, Anunoby IA, et al. Pilot study of real-world monitoring of the heart rate variability in amyotrophic lateral sclerosis. Front Artif Intell. 2022;5:910049.
   PubMedGoogle Scholar
• Jaafar N, Malek E, Ismail H, Salameh J. Nonmotor symptoms in amyotrophic lateral sclerosis and their correlation with disease progression. J Clin Neuromuscul Dis. 2021;23:1–6.
   PubMedGoogle Scholar
• Wasner M, Bold U, Vollmer TC, Borasio GD. Sexuality in patients with amyotrophic lateral sclerosis and their partners. J Neurol. 2004;251:445–8.
   PubMed Web of Science ®Google Scholar
• Piccione EA, Sletten DM, Staff NP, Low PA. Autonomic system and amyotrophic lateral sclerosis. Muscle Nerve. 2015;51:676–9.
   PubMed Web of Science ®Google Scholar
• Wang Y, Yang X, Han Q, Liu M, Zhou C. Prevalence of sialorrhea among amyotrophic lateral sclerosis patients: a systematic review and meta-analysis. J Pain Symptom Manage. 2022;63:e387–e96.
   PubMed Web of Science ®Google Scholar
• Baltadzhieva R, Gurevich T, Korczyn AD. Autonomic impairment in amyotrophic lateral sclerosis. Curr Opin Neurol. 2005;18:487–93.
   PubMed Web of Science ®Google Scholar
• Gunther R, Richter N, Sauerbier A, Chaudhuri KR, Martinez-Martin P, Storch A, et al. Non-motor symptoms in patients suffering from motor neuron diseases. Front Neurol. 2016;7:117.
   PubMed Web of Science ®Google Scholar
• Jackson CE, McVey AL, Rudnicki S, Dimachkie MM, Barohn RJ. Symptom management and end-of-life care in amyotrophic lateral sclerosis. Neurol Clin. 2015;33:889–908.
   PubMed Web of Science ®Google Scholar
• Liu G, Hrabe J, Sanchez R. Colostomy as a definitive treatment in an ALS patient with acute colonic pseudo-obstruction refractory to medical management, a case report. BMC Neurol. 2022;22:366.
   Google Scholar
• Chen JH, Wu SC, Chen HJ, Kao CH, Tseng CH, Tsai CH. Risk of developing pressure sore in amyotrophic lateral sclerosis patients – a nationwide cohort study. J Eur Acad Dermatol Venereol. 2018;32:1589–96.
   PubMed Web of Science ®Google Scholar
• Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, MacPhee G, et al. Prevalence of nonmotor symptoms in Parkinson’s disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord. 2007;22:1623–9.
   PubMed Web of Science ®Google Scholar
• Mollenhauer B, Trautmann E, Sixel-Doring F, Wicke T, Ebentheuer J, Schaumburg M, et al. Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort. Neurology 2013;81:1226–34.
   PubMed Web of Science ®Google Scholar
• Antonini A, Barone P, Marconi R, Morgante L, Zappulla S, Pontieri FE, et al. The progression of non-motor symptoms in Parkinson’s disease and their contribution to motor disability and quality of life. J Neurol. 2012;259:2621–31.
   PubMed Web of Science ®Google Scholar
• Muller B, Assmus J, Herlofson K, Larsen JP, Tysnes OB. Importance of motor vs. non-motor symptoms for health-related quality of life in early Parkinson’s disease. Parkinsonism Relat Disord. 2013;19:1027–32.
   PubMed Web of Science ®Google Scholar
• Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. Movement disorder society-sponsored revision of the unified Parkinson’s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23:2129–70.
   PubMed Web of Science ®Google Scholar
• Chaudhuri KR, Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord. 2006;21:916–23.
   PubMed Web of Science ®Google Scholar
• Chaudhuri KR, Martinez-Martin P, Brown RG, Sethi K, Stocchi F, Odin P, et al. The metric properties of a novel non-motor symptoms scale for Parkinson’s disease: results from an international pilot study. Mov Disord. 2007;22:1901–11.
   PubMed Web of Science ®Google Scholar
• Chaudhuri KR, Schrag A, Weintraub D, Rizos A, Rodriguez-Blazquez C, Mamikonyan E, et al. The movement disorder society nonmotor rating scale: initial validation study. Mov Disord. 2020;35:116–33.
   PubMed Web of Science ®Google Scholar
• Todorova A, Jenner P, Ray Chaudhuri K. Non-motor Parkinson’s: integral to motor Parkinson’s, yet often neglected. Pract Neurol. 2014;14:310–22.
   PubMedGoogle Scholar
• Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging. 2003;24:197–211.
   PubMed Web of Science ®Google Scholar
• Titova N, Padmakumar C, Lewis SJG, Chaudhuri KR. Parkinson’s: a syndrome rather than a disease? J Neural Transm. 2017;124:907–14.
   PubMed Web of Science ®Google Scholar
• Chaudhuri KR, Schapira AH. Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. Lancet Neurol. 2009;8:464–74.
   PubMed Web of Science ®Google Scholar
• Jellinger KA. Neuropathology of sporadic Parkinson’s disease: evaluation and changes of concepts. Mov Disord. 2012;27:8–30.
   PubMed Web of Science ®Google Scholar
• Brettschneider J, Del Tredici K, Toledo JB, Robinson JL, Irwin DJ, Grossman M, et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol. 2013;74:20–38.
   PubMed Web of Science ®Google Scholar
• Erro R, Vitale C, Amboni M, Picillo M, Moccia M, Longo K, et al. The heterogeneity of early Parkinson’s disease: a cluster analysis on newly diagnosed untreated patients. PLoS One. 2013;8:e70244.
   PubMed Web of Science ®Google Scholar
• Mu J, Chaudhuri KR, Bielza C, de Pedro-Cuesta J, Larrañaga P, Martinez-Martin P. Parkinson’s disease subtypes identified from cluster analysis of motor and non-motor symptoms. Front Aging Neurosci. 2017;9:301.
   PubMed Web of Science ®Google Scholar
• Marras C, Chaudhuri KR. Nonmotor features of Parkinson’s disease subtypes. Mov Disord. 2016;31:1095–102.
   PubMed Web of Science ®Google Scholar
• Selikhova M, Williams DR, Kempster PA, Holton JL, Revesz T, Lees AJ. A clinico-pathological study of subtypes in Parkinson’s disease. Brain. 2009;132:2947–57.
   PubMed Web of Science ®Google Scholar
• Pont-Sunyer C, Hotter A, Gaig C, Seppi K, Compta Y, Katzenschlager R, et al. The onset of nonmotor symptoms in Parkinson’s disease (the ONSET PD study). Mov Disord. 2015;30:229–37.
   PubMed Web of Science ®Google Scholar
• Sauerbier A, Jenner P, Todorova A, Chaudhuri KR. Non motor subtypes and Parkinson’s disease. Parkinsonism Relat Disord. 2016;22 Suppl 1: S41–S6.
   PubMed Web of Science ®Google Scholar
• Perez-Lloret S, Barrantes FJ. Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson’s disease. NPJ Parkinsons Dis 2016;2:16001.
   PubMed Web of Science ®Google Scholar
• Huot P, Fox SH, Brotchie JM. The serotonergic system in Parkinson’s disease. Prog Neurobiol. 2011;95:163–212.
   PubMed Web of Science ®Google Scholar
• Marras C, Chaudhuri KR, Titova N, Mestre TA. Therapy of Parkinson’s disease subtypes. Neurotherapeutics. 2020;17:1366–77.
   PubMed Web of Science ®Google Scholar
• Batla A, Phe V, De Min L, Panicker JN. Nocturia in Parkinson’s disease: why does it occur and how to manage? Mov Disord Clin Pract. 2016;3:443–51.
   PubMed Web of Science ®Google Scholar
• Frazzitta G, Ferrazzoli D, Folini A, Palamara G, Maestri R. Severe constipation in parkinson’s disease and in parkinsonisms: prevalence and affecting factors. Front Neurol. 2019;10:621.
   PubMed Web of Science ®Google Scholar
• Kim JS, Youn J, Suh MK, Kim TE, Chin J, Park S, et al. Cognitive and motor aspects of parkinson’s disease associated with dysphagia. Can J Neurol Sci. 2015;42:395–400.
   PubMed Web of Science ®Google Scholar
• Lazcano-Ocampo C, Wan YM, van Wamelen DJ, Batzu L, Boura I, Titova N, et al. Identifying and responding to fatigue and apathy in Parkinson’s disease: a review of current practice. Expert Rev Neurother. 2020;20:477–95.
   PubMed Web of Science ®Google Scholar
• de la Fuente-Fernandez R. Frontostriatal cognitive staging in Parkinson’s disease. Parkinsons Dis. 2012;2012:1–8.
   Web of Science ®Google Scholar
• Vasconcellos LF, Pereira JS. Parkinson’s disease dementia: diagnostic criteria and risk factor review. J Clin Exp Neuropsychol. 2015;37:988–93.
   PubMed Web of Science ®Google Scholar
• Watson GS, Leverenz JB. Profile of cognitive impairment in Parkinson’s disease. Brain Pathol. 2010;20:640–5.
   PubMed Web of Science ®Google Scholar
• Benbrika S, Desgranges B, Eustache F, Viader F. Cognitive, emotional and psychological manifestations in amyotrophic lateral sclerosis at baseline and overtime: a review. Front Neurosci. 2019;13:951.
   PubMed Web of Science ®Google Scholar
• Harmell AL, Neikrug AB, Palmer BW, Avanzino JA, Liu L, Maglione JE, et al. Obstructive sleep apnea and cognition in Parkinson’s disease. Sleep Med. 2016;21:28–34.
   PubMed Web of Science ®Google Scholar
• Ray Chaudhuri K, Poewe W, Brooks D. Motor and nonmotor complications of levodopa: phenomenology, risk factors, and imaging features. Mov Disord. 2018;33:909–19.
   PubMed Web of Science ®Google Scholar
• Storch A, Schneider CB, Wolz M, Sturwald Y, Nebe A, Odin P, et al. Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complications. Neurology 2013;80:800–9.
   PubMed Web of Science ®Google Scholar
• Witjas T, Kaphan E, Azulay JP, Blin O, Ceccaldi M, Pouget J, et al. Nonmotor fluctuations in Parkinson’s disease: frequent and disabling. Neurology 2002;59:408–13.
   PubMed Web of Science ®Google Scholar
• Ffytche DH, Aarsland D. Psychosis in Parkinson’s Disease. Int Rev Neurobiol 2017;133:585–622.
   PubMed Web of Science ®Google Scholar
• Poletti M, Bonuccelli U. Impulse control disorders in Parkinson’s disease: the role of personality and cognitive status. J Neurol. 2012;259:2269–77.
   PubMed Web of Science ®Google Scholar
• Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, et al. MDS research criteria for prodromal Parkinson’s disease. Mov Disord. 2015;30:1600–11.
   PubMed Web of Science ®Google Scholar
• Benatar M, Turner MR, Wuu J. Defining pre-symptomatic amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:303–9.
   PubMed Web of Science ®Google Scholar
• Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Prognostic factors in ALS: A critical review. Amyotroph Lateral Scler. 2009;10:310–23.
   PubMed Web of Science ®Google Scholar
• Turner MR, Goldacre R, Talbot K, Goldacre MJ. Psychiatric disorders prior to amyotrophic lateral sclerosis. Ann Neurol. 2016;80:935–8.
   PubMed Web of Science ®Google Scholar
• Seppi K, Ray Chaudhuri K, Coelho M, Fox SH, Katzenschlager R, Perez Lloret S, et al. Update on treatments for nonmotor symptoms of Parkinson’s disease-an evidence-based medicine review. Mov Disord. 2019;34:180–98.
   PubMed Web of Science ®Google Scholar
• Titova N, Chaudhuri KR. Personalized medicine in Parkinson’s disease: Time to be precise. Mov Disord. 2017;32:1147–54.
   PubMed Web of Science ®Google Scholar
• Chaudhuri KR, Prieto-Jurcynska C, Naidu Y, Mitra T, Frades-Payo B, Tluk S, et al. The nondeclaration of nonmotor symptoms of Parkinson’s disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord. 2010;25:704–9.
   PubMed Web of Science ®Google Scholar
• LeWitt PA, Chaudhuri KR. Unmet needs in Parkinson disease: motor and non-motor. Parkinsonism Relat Disord. 2020;80 Suppl 1: S7–S12.
   PubMed Web of Science ®Google Scholar
• Beswick E, Forbes D, Hassan Z, Wong C, Newton J, Carson A, et al. A systematic review of non-motor symptom evaluation in clinical trials for amyotrophic lateral sclerosis. J Neurol. 2022;269:411–26.
   PubMed Web of Science ®Google Scholar
• Martinez-Martin P, Rodriguez-Blazquez C, Forjaz MJ, Kurtis MM, Skorvanek M. Measurement of nonmotor symptoms in clinical practice. Int Rev Neurobiol 2017;133:291–345.
   PubMed Web of Science ®Google Scholar
• Fang T, Al Khleifat A, Stahl DR, Lazo La Torre C, Murphy C, Young C, Uk-Mnd Lical S, et al. Comparison of the King’s and MiToS staging systems for ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:227–32.
   PubMed Web of Science ®Google Scholar
• Balendra R, Jones A, Jivraj N, Knights C, Ellis CM, Burman R, et al. Estimating clinical stage of amyotrophic lateral sclerosis from the ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:279–84.
   PubMed Web of Science ®Google Scholar
• Chio A, Hammond ER, Mora G, Bonito V, Filippini G. Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2015;86:38–44.
   PubMed Web of Science ®Google Scholar
• Roche JC, Rojas-Garcia R, Scott KM, Scotton W, Ellis CE, Burman R, et al. A proposed staging system for amyotrophic lateral sclerosis. Brain. 2012;135:847–52.
   PubMed Web of Science ®Google Scholar
• Hassan A, Wu SS, Schmidt P, Simuni T, Giladi N, Miyasaki JM, et al. The profile of long-term parkinson’s disease survivors with 20 years of disease duration and beyond. J Parkinsons Dis. 2015;5:313–9.
   PubMedGoogle Scholar
• Ishihara LS, Cheesbrough A, Brayne C, Schrag A. Estimated life expectancy of Parkinson’s patients compared with the UK population. J Neurol Neurosurg Psychiatry. 2007;78:1304–9.
   PubMed Web of Science ®Google Scholar
• Corcia P, Pradat PF, Salachas F, Bruneteau G, Forestier N, Seilhean D, et al. Causes of death in a post-mortem series of ALS patients. Amyotroph Lateral Scler. 2008;9:59–62.
   PubMed Web of Science ®Google Scholar
• Chaudhuri KR, Pal S, DiMarco A, Whately-Smith C, Bridgman K, Mathew R, et al. The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2002;73:629–35.
   PubMed Web of Science ®Google Scholar
• Chaudhuri KR, Rizos A, Trenkwalder C, Rascol O, Pal S, Martino D, et al. King’s Parkinson’s disease pain scale, the first scale for pain in PD: an international validation. Mov Disord. 2015;30:1623–31.
   PubMed Web of Science ®Google Scholar
• Boentert M. Sleep disturbances in patients with amyotrophic lateral sclerosis: current perspectives. Nat Sci Sleep. 2019;11:97–111.
   PubMed Web of Science ®Google Scholar
• Grossman AB, Woolley-Levine S, Bradley WG, Miller RG. Detecting neurobehavioral changes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2007;8:56–61.
   PubMed Web of Science ®Google Scholar
• Lillo P, Mioshi E, Zoing MC, Kiernan MC, Hodges JR. How common are behavioural changes in amyotrophic lateral sclerosis? Amyotroph Lateral Scler. 2011;12:45–51.
   PubMed Web of Science ®Google Scholar
• Wei Q, Chen X, Cao B, Ou R, Zhao B, Wu Y, et al. Associations between neuropsychiatric symptoms and cognition in Chinese patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:358–65.
   PubMed Web of Science ®Google Scholar
• Viguera C, Wang J, Mosmiller E, Cerezo A, Maragakis NJ. Olfactory dysfunction in amyotrophic lateral sclerosis. Ann Clin Transl Neurol. 2018;5:976–81.
   PubMed Web of Science ®Google Scholar
• Gunther R, Schrempf W, Hahner A, Hummel T, Wolz M, Storch A, et al. Impairment in respiratory function contributes to olfactory impairment in amyotrophic lateral sclerosis. Front Neurol. 2018;9:79.
   PubMed Web of Science ®Google Scholar
• Bergmann M, Volpel M, Kuchelmeister K. Onuf’s nucleus is frequently involved in motor neuron disease/amyotrophic lateral sclerosis. J Neurol Sci. 1995;129:141–6.
   PubMed Web of Science ®Google Scholar
• Carvalho M, Schwartz MS, Swash M. Involvement of the external anal sphincter in amyotrophic lateral sclerosis. Muscle Nerve. 1995;18:848–53.
   PubMed Web of Science ®Google Scholar
• Gibbons CJ, Thornton EW, Young CA. The patient experience of fatigue in motor neurone disease. Front Psychol. 2013;4:788.
   PubMed Web of Science ®Google Scholar
• Dhawan V, Healy DG, Pal S, Chaudhuri KR. Sleep-related problems of Parkinson’s disease. Age Ageing. 2006;35:220–8.
   PubMed Web of Science ®Google Scholar
• Aarsland D, Brønnick K, Ehrt U, De Deyn PP, Tekin S, Emre M, et al. Neuropsychiatric symptoms in patients with Parkinson’s disease and dementia: frequency, profile and associated care giver stress. J Neurol Neurosurg Psychiatry. 2007;78:36–42.
   PubMed Web of Science ®Google Scholar
• Doty RL. Olfactory dysfunction in Parkinson disease. Nat Rev Neurol. 2012;8:329–39.
   PubMed Web of Science ®Google Scholar
• Suttrup I, Warnecke T. Dysphagia in Parkinson’s disease. Dysphagia 2016;31:24–32.
   PubMed Web of Science ®Google Scholar
• Metta V, Leta V, Mrudula KR, Prashanth LK, Goyal V, Borgohain R, et al. Gastrointestinal dysfunction in Parkinson’s disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation. J Neurol. 2022;269:1154–63.
   PubMed Web of Science ®Google Scholar
• Yeo L, Singh R, Gundeti M, Barua JM, Masood J. Urinary tract dysfunction in Parkinson’s disease: a review. Int Urol Nephrol. 2012;44:415–24.
   PubMed Web of Science ®Google Scholar
• Rukavina K, Leta V, Sportelli C, Buhidma Y, Duty S, Malcangio M, et al. Pain in Parkinson’s disease: new concepts in pathogenesis and treatment. Curr Opin Neurol. 2019;32:579–88.
   PubMed Web of Science ®Google Scholar